https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-06-01 / Lancet Oncol. 2014 Jun;15(7):e257-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-06-01 / Lancet Oncol. 2014 Jun;15(7):e257-672014-06-01 00:00:002019-02-15 08:35:59Clinical use of dendritic cells for cancer therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-03-05 / Sci Transl Med 2014 Mar;6(226):226ra32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-03-05 / Sci Transl Med 2014 Mar;6(226):226ra322014-03-05 00:00:002019-02-15 08:36:15Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-12-03 / Front Immunol 2013 Dec;4:417
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-12-03 / Front Immunol 2013 Dec;4:4172013-12-03 00:00:002019-02-15 08:36:00Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-03-21 / Cancer Lett. 2013 Aug;336(2):253-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-03-21 / Cancer Lett. 2013 Aug;336(2):253-92013-03-21 00:00:002019-02-15 08:36:01Blockade of PD-1/PD-L1 immune checkpoint during DC vaccination induces potent protective immunity against breast cancer in hu-SCID mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-03-22 / Nat. Rev. Cancer 2012 Mar;12(4):252-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-03-22 / Nat. Rev. Cancer 2012 Mar;12(4):252-642012-03-22 00:00:002019-02-15 08:35:56The blockade of immune checkpoints in cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-06-01 / J. Immunother. 2011 Jun;34(5):409-18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-06-01 / J. Immunother. 2011 Jun;34(5):409-182011-06-01 00:00:002019-02-15 08:36:02PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-29 / Clin. Cancer Res. 2009 Oct;15(19):6267-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-29 / Clin. Cancer Res. 2009 Oct;15(19):6267-762009-09-29 00:00:002019-02-15 08:36:11Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma